Fatal ascending paralysis after typhoid vaccine: Guillain and Barré's description of the very first case

IF 4.5 3区 医学 Q2 IMMUNOLOGY Vaccine Pub Date : 2024-11-12 DOI:10.1016/j.vaccine.2024.126443
Eelco F.M. Wijdicks
{"title":"Fatal ascending paralysis after typhoid vaccine: Guillain and Barré's description of the very first case","authors":"Eelco F.M. Wijdicks","doi":"10.1016/j.vaccine.2024.126443","DOIUrl":null,"url":null,"abstract":"<div><div><em>Background:</em> Albeit rare, Guillain - Barré syndrome (GBS) has been associated with several vaccines. Surveys of these associations have not looked before 1950. Herein, I revisit the first described case of vaccine-associated GBS, manifesting during the Great War and to prevent typhoid.</div><div><em>Methods:</em> Review of primary and secondary source material. Description of a landmark case.</div><div><em>Results:</em> Review of a report of a 31-year-old brigadier who was revaccinated with “vaccin TAB” (a triple antityphoid-paratyphoid vaccine A and B) which days later was followed by rapid progression of limb weakness, oropharyngeal weakness and fatal neuromuscular respiratory weakness. Cerebrospinal fluid showed mild pleocytosis and increased protein (albumen). There was a normal brain and spinal cord at autopsy.</div><div><em>Conclusion:</em> This is the first reported case of a vaccine-associated GBS<em>.</em></div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"42 26","pages":"Article 126443"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X24011253","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Albeit rare, Guillain - Barré syndrome (GBS) has been associated with several vaccines. Surveys of these associations have not looked before 1950. Herein, I revisit the first described case of vaccine-associated GBS, manifesting during the Great War and to prevent typhoid.
Methods: Review of primary and secondary source material. Description of a landmark case.
Results: Review of a report of a 31-year-old brigadier who was revaccinated with “vaccin TAB” (a triple antityphoid-paratyphoid vaccine A and B) which days later was followed by rapid progression of limb weakness, oropharyngeal weakness and fatal neuromuscular respiratory weakness. Cerebrospinal fluid showed mild pleocytosis and increased protein (albumen). There was a normal brain and spinal cord at autopsy.
Conclusion: This is the first reported case of a vaccine-associated GBS.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
接种伤寒疫苗后出现致命的上升性麻痹:吉兰(Guillain)和巴雷(Barré)对首例病例的描述。
背景:尽管罕见,但吉兰-巴雷综合征(GBS)与多种疫苗有关。有关这些关联的调查在 1950 年以前从未见过。在此,我重温了第一例描述的疫苗相关吉-巴氏综合征病例,该病例出现在大战期间,当时是为了预防伤寒:方法:回顾原始和二手资料。描述一个具有里程碑意义的病例:回顾一名 31 岁准将的报告,他重新接种了 "vaccin TAB"(A 型和 B 型三联抗伤寒-副伤寒疫苗),几天后出现四肢无力、口咽无力和致命性神经肌肉呼吸无力的快速发展。脑脊液显示轻度多细胞和蛋白(白蛋白)增加。尸检结果显示大脑和脊髓正常:这是首例报告的疫苗相关性 GBS 病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
期刊最新文献
Re: Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection: Reply to the commentary written by Christine Velicer, Alain Luxembourg, Ya-Ting Chen, Melvin Kohn, and Alfred Saah, Merck & Co., Inc., Kenilworth, NJ, USA on the IARC-India HPV vaccine study. The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications Assessing human B cell responses to influenza virus vaccines and adjuvants in a PBMC-derived in vitro culture system The effectiveness of vaccines against COVID-19 in Mexico: A time series approach Exploring Chatbot contributions to enhancing vaccine literacy and uptake: A scoping review of the literature
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1